FRANKFURT, July 6 (Reuters) - German drug and chemical group Bayer (BAYG.DE: Quote, Profile, Research) raised around 1.2 billion euros ($1.5 billion) on Thursday from a capital increase to help fund its purchase of Schering (SCHG.DE: Quote, Profile, Research). The company said in a statement that the shares had been placed at 34.75 euros apiece, a discount of 2.6 percent to Wednesday’s closing price, confirming an earlier Reuters report based on dealer comments.
